Demonstration that fbiC Is Required by Mycobacterium bovis BCG for Coenzyme F(420) and FO Biosynthesis

Using the nitroimidazopyran-based antituberculosis drug PA-824 as a selective agent, transposon-generated Mycobacterium bovis strain BCG (M. bovis) mutants that could not make coenzyme F(420) were identified. Four independent mutants that could not make F(420) or the biosynthesis intermediate FO wer...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Bacteriol
Principais autores:	Choi, Kwang-Pil, Kendrick, Nathan, Daniels, Lacy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Physiology and Metabolism
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC134996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11948155/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JB.184.9.2420-2428.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!